News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Harvard Bioscience Inc. Reports Second Quarter 2006 Results
August 4, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today reported unaudited financial highlights for the three and six months ended June 30, 2006.(1)
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
April 29, 2026
·
2 min read
·
Gabrielle Masson
Earnings
AstraZeneca bullish on $80B sales goal after beating expectations, Phase 3 data wins
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
GSK’s Shingrix strategy shift drives sales beat even as vaccines slow
April 29, 2026
·
2 min read
·
Tristan Manalac
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
·
2 min read
·
Nick Paul Taylor
